This article captures the proceedings of a meeting aimed at defining clinically meaningful effects for use in randomized controlled trials for psychopharmacological agents.

Keefe RS, Kraemer HC, Epstein RS, Frank E, Haynes G, Laughren TP, McNulty J, Reed SD, Sanchez J, Leon AC. Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials.  Innovations in Clinical Neuroscience, 2013; 10(5-6 Suppl. A): 4S-19S.  (PMCID:  PMC3719483).